Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

BV Investments Global Bayer Net Worth & Insider Trades

BV Investments Global Bayer Crispr Therapeutics Ag

As of January 30, 2018

What is BV Investments Global Bayer's Net Worth?

The current estimated net worth of Crispr Therapeutics Ag's BV Investments Global Bayer is estimated to be about $328.34M . BV Investments Global Bayer owns about 5,708,747 units of Crispr Therapeutics Ag common stock. Recently at Crispr Therapeutics Ag, BV Investments Global Bayer has sold an estimated value of $0 worth.

What is BV Investments Global Bayer's Past Insider Trading?

BV Investments Global Bayer's largest purchase order was 527,472 units , worth over $12M on January 30, 2018. In total, BV Investments Global Bayer has made about 1 transaction recently at Crispr Therapeutics Ag. BV Investments Global Bayer usually trades in January, with the busiest year in 2018.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AKTIENGESELLSCHAFT BAYER, BV Investments Global Bayer

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is BV Investments Global Bayer's' Mailing Address?

  • Mailing address is C/o Crispr Therapeutics Ag 200 Sidney Street Cambridge MA 02139 MA

What are Crispr Therapeutics Ag's Past Insider Trades?

Crispr Therapeutics Ag's most recent insider trade came on June 1, 2023 by Samarth Kulkarni who sold 25,000 units worth $1.62M . In the last 7 years, insiders at Crispr Therapeutics Ag have sold an estimated value of $402.48M and bought an estimated value of $60.43M worth of shares. Insider trading is most common in June, with the busiest year in 2017. The most active traders at the company are Samarth Kulkarni, Chief Executive Officer,  Phd Bradley Bolzon, Director,  and Rodger Novak, President .

CRISPR Therapeutics AG Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...